ID   LIN41_MOUSE             Reviewed;         855 AA.
AC   Q1PSW8;
DT   06-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 1.
DT   07-APR-2021, entry version 120.
DE   RecName: Full=E3 ubiquitin-protein ligase TRIM71;
DE            EC=2.3.2.27;
DE   AltName: Full=Protein lin-41 homolog;
DE            Short=mLin41;
DE   AltName: Full=RING-type E3 ubiquitin transferase TRIM71 {ECO:0000305};
DE   AltName: Full=Tripartite motif-containing protein 71;
GN   Name=Trim71; Synonyms=Gm1127, Lin41;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND DEVELOPMENTAL STAGE.
RX   PubMed=16477647; DOI=10.1002/dvdy.20712;
RA   Kanamoto T., Terada K., Yoshikawa H., Furukawa T.;
RT   "Cloning and regulation of the vertebrate homologue of lin-41 that
RT   functions as a heterochronic gene in Caenorhabditis elegans.";
RL   Dev. Dyn. 235:1142-1149(2006).
RN   [2]
RP   IDENTIFICATION.
RX   PubMed=16245339; DOI=10.1002/dvdy.20591;
RA   Lancman J.J., Caruccio N.C., Harfe B.D., Pasquinelli A.E., Schageman J.J.,
RA   Pertsemlidis A., Fallon J.F.;
RT   "Analysis of the regulation of lin-41 during chick and mouse limb
RT   development.";
RL   Dev. Dyn. 234:948-960(2005).
RN   [3]
RP   IDENTIFICATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=16247770; DOI=10.1002/dvdy.20599;
RA   Maller Schulman B.R., Esquela-Kerscher A., Slack F.J.;
RT   "Reciprocal expression of lin-41 and the microRNAs let-7 and mir-125 during
RT   mouse embryogenesis.";
RL   Dev. Dyn. 234:1046-1054(2005).
RN   [4]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=19098426; DOI=10.4161/cc.7.24.7397;
RA   Maller Schulman B.R., Liang X., Stahlhut C., DelConte C., Stefani G.,
RA   Slack F.J.;
RT   "The let-7 microRNA target gene, Mlin41/Trim71 is required for mouse
RT   embryonic survival and neural tube closure.";
RL   Cell Cycle 7:3935-3942(2008).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INTERACTION WITH AGO2,
RP   AND MUTAGENESIS OF CYS-12 AND CYS-15.
RX   PubMed=19898466; DOI=10.1038/ncb1987;
RA   Rybak A., Fuchs H., Hadian K., Smirnova L., Wulczyn E.A., Michel G.,
RA   Nitsch R., Krappmann D., Wulczyn F.G.;
RT   "The let-7 target gene mouse lin-41 is a stem cell specific E3 ubiquitin
RT   ligase for the miRNA pathway protein Ago2.";
RL   Nat. Cell Biol. 11:1411-1420(2009).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DISRUPTION PHENOTYPE,
RP   AUTOUBIQUITINATION, AND INTERACTION WITH AGO2 AND SHCBP1.
RX   PubMed=22508726; DOI=10.1101/gad.187641.112;
RA   Chen J., Lai F., Niswander L.;
RT   "The ubiquitin ligase mLin41 temporally promotes neural progenitor cell
RT   maintenance through FGF signaling.";
RL   Genes Dev. 26:803-815(2012).
RN   [7]
RP   FUNCTION, RNA-BINDING, SUBCELLULAR LOCATION, INTERACTION WITH AGO2, TISSUE
RP   SPECIFICITY, AND INDUCTION.
RX   PubMed=22735451; DOI=10.1038/ncomms1909;
RA   Chang H.M., Martinez N.J., Thornton J.E., Hagan J.P., Nguyen K.D.,
RA   Gregory R.I.;
RT   "Trim71 cooperates with microRNAs to repress Cdkn1a expression and promote
RT   embryonic stem cell proliferation.";
RL   Nat. Commun. 3:923-923(2012).
RN   [8]
RP   FUNCTION.
RX   PubMed=23125361; DOI=10.1093/nar/gks1032;
RA   Loedige I., Gaidatzis D., Sack R., Meister G., Filipowicz W.;
RT   "The mammalian TRIM-NHL protein TRIM71/LIN-41 is a repressor of mRNA
RT   function.";
RL   Nucleic Acids Res. 41:518-532(2013).
RN   [9]
RP   FUNCTION, DISRUPTION PHENOTYPE, TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RX   PubMed=25883935; DOI=10.3389/fcell.2015.00020;
RA   Cuevas E., Rybak-Wolf A., Rohde A.M., Nguyen D.T., Wulczyn F.G.;
RT   "Lin41/Trim71 is essential for mouse development and specifically expressed
RT   in postnatal ependymal cells of the brain.";
RL   Front. Cell Dev. Biol. 3:20-20(2015).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that cooperates with the
CC       microRNAs (miRNAs) machinery and promotes embryonic stem cells
CC       proliferation and maintenance (PubMed:19898466). Binds to miRNAs and
CC       associates with AGO2, participating in post-transcriptional repression
CC       of transcripts such as CDKN1A. Facilitates the G1-S transition to
CC       promote rapid embryonic stem cell self-renewal by repressing CDKN1A
CC       expression (PubMed:22735451). In addition, participates in post-
CC       transcriptional mRNA repression in a miRNA independent mechanism
CC       (PubMed:23125361). Required to maintain proliferation and prevent
CC       premature differentiation of neural progenitor cells during early
CC       neural development: positively regulates FGF signaling by controlling
CC       the stability of SHCBP1 (PubMed:22735451). Specific regulator of miRNA
CC       biogenesis. miRNA Binds MIR29A hairpin and postranscriptionally
CC       modulates MIR29A levels, which indirectly regulates TET proteins
CC       expression (By similarity). {ECO:0000250|UniProtKB:Q2Q1W2,
CC       ECO:0000269|PubMed:19898466, ECO:0000269|PubMed:22735451,
CC       ECO:0000269|PubMed:23125361}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27;
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts (via NHL repeats) with AGO2; the interaction
CC       increases in presence of RNA (PubMed:19898466, PubMed:22508726,
CC       PubMed:22735451). Interacts with HSP90AA1. Interacts (via NHL repeats)
CC       with MOV10, PABPC1, PUM1, PUM2, STAU2, XRN1 and XRN2 in an RNA-
CC       dependent manner (By similarity). Interacts with SHCBP1; leading to
CC       enhance its stability (PubMed:22508726). {ECO:0000250|UniProtKB:Q2Q1W2,
CC       ECO:0000269|PubMed:19898466, ECO:0000269|PubMed:22508726,
CC       ECO:0000269|PubMed:22735451}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000269|PubMed:19898466,
CC       ECO:0000269|PubMed:22508726, ECO:0000269|PubMed:22735451}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in undifferentiated embryonic stem
CC       cells (ESCs). Expressed in the epiblast and in interfollicular
CC       epidermal stem cells during early development. Also expressed in male
CC       germ cells and in the reproductive tract. Highly expressed in
CC       neuroepithelial cells, and its expression declines as neurogenesis
CC       proceeds (at protein level). Expressed in ependymal cells of the brain
CC       (PubMed:25883935). {ECO:0000269|PubMed:19898466,
CC       ECO:0000269|PubMed:22508726, ECO:0000269|PubMed:22735451,
CC       ECO:0000269|PubMed:25883935}.
CC   -!- DEVELOPMENTAL STAGE: Expression is first detected at 8.5 dpc, increases
CC       to highest levels at 14.5 dpc and remains elevated through the newborn
CC       stage. Expressed in developing limb buds and tail buds starting from
CC       9.5 dpc. At 9.5 dpc, expression is prominent in the entire embryo, with
CC       the exception of the primordial cardiac sac. At 10.5 dpc, expression
CC       reduces to the neuroepithelium, branchial arches, spinal cord, somites,
CC       limb, and tail buds. At the onset of central nervous system
CC       development, the neuroepithelium shows a prominent staining between 9.5
CC       dpc and 10.5 dpc. Thereafter, expression is unevenly distributed in a
CC       progressively thinner layer along the inner surface of the ventricle.
CC       Expression is intense at the bumps corresponding to the nascent limb
CC       buds around 10.5 dpc. Shortly thereafter, as the limb buds emerge from
CC       the body and expand, expression declines and is limited to the most
CC       distal surface at 12.5 dpc. At 13.5 dpc it is no longer possible to
CC       identify expression in either the developing nervous system, the limb
CC       or the tail buds. From postnatal day 10 (P10) to the adulthood,
CC       expressed in cells lining the wall of the four ventricles of the
CC       postnatal brain (PubMed:25883935). {ECO:0000269|PubMed:16247770,
CC       ECO:0000269|PubMed:16477647, ECO:0000269|PubMed:25883935}.
CC   -!- INDUCTION: Negatively regulated by the microRNA (miRNA) let-7 which
CC       causes degradation of the mRNA encoding this protein. This requires a
CC       let-7 complementary site (LCS) in the 3'-UTR of the mRNA encoding this
CC       protein. {ECO:0000269|PubMed:22735451}.
CC   -!- DOMAIN: The NHL domain, containing the 6 NHL repeats, is necessary and
CC       sufficient to target RNA but not to repress mRNA. The minimal region
CC       needed to execute repression consists of the coiled coil domain and the
CC       Filamin repeat. The RING-type domain is dispensable for mRNA
CC       repression. {ECO:0000250|UniProtKB:Q2Q1W2}.
CC   -!- PTM: Autoubiquitinated. {ECO:0000269|PubMed:22508726}.
CC   -!- DISRUPTION PHENOTYPE: Embryonic lethality at 9.5 dpc, due to a neural
CC       tube closure defect in the anterior craniofacial region of the neural
CC       tube, corresponding to the forebrain/midbrain boundary. Reduced cell
CC       proliferation in the neuroepithelium. {ECO:0000269|PubMed:19098426,
CC       ECO:0000269|PubMed:22508726, ECO:0000269|PubMed:25883935}.
CC   -!- SIMILARITY: Belongs to the TRIM/RBCC family. {ECO:0000305}.
CC   -!- CAUTION: Reported to mediate ubiquitination and subsequent degradation
CC       of AGO2 (PubMed:19898466). However, this result is subject to
CC       discussion and later reports suggest that, while it interacts with
CC       AGO2, it is not involved in AGO2 ubiquitination (PubMed:22508726,
CC       PubMed:22735451). {ECO:0000305|PubMed:19898466,
CC       ECO:0000305|PubMed:22508726, ECO:0000305|PubMed:22735451}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ005956; AAY55947.1; -; mRNA.
DR   CCDS; CCDS40793.1; -.
DR   RefSeq; NP_001035968.1; NM_001042503.2.
DR   SMR; Q1PSW8; -.
DR   BioGRID; 561929; 10.
DR   STRING; 10090.ENSMUSP00000107447; -.
DR   iPTMnet; Q1PSW8; -.
DR   PhosphoSitePlus; Q1PSW8; -.
DR   PaxDb; Q1PSW8; -.
DR   PeptideAtlas; Q1PSW8; -.
DR   PRIDE; Q1PSW8; -.
DR   ProteomicsDB; 292260; -.
DR   Antibodypedia; 45336; 179 antibodies.
DR   Ensembl; ENSMUST00000111816; ENSMUSP00000107447; ENSMUSG00000079259.
DR   GeneID; 636931; -.
DR   KEGG; mmu:636931; -.
DR   UCSC; uc009rxp.1; mouse.
DR   CTD; 131405; -.
DR   MGI; MGI:2685973; Trim71.
DR   eggNOG; KOG2177; Eukaryota.
DR   GeneTree; ENSGT00940000159099; -.
DR   HOGENOM; CLU_008645_4_1_1; -.
DR   InParanoid; Q1PSW8; -.
DR   OMA; CGSFHHK; -.
DR   OrthoDB; 489543at2759; -.
DR   PhylomeDB; Q1PSW8; -.
DR   TreeFam; TF331018; -.
DR   Reactome; R-MMU-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 636931; 1 hit in 52 CRISPR screens.
DR   ChiTaRS; Trim71; mouse.
DR   PRO; PR:Q1PSW8; -.
DR   Proteomes; UP000000589; Chromosome 9.
DR   RNAct; Q1PSW8; protein.
DR   Bgee; ENSMUSG00000079259; Expressed in primitive streak and 103 other tissues.
DR   Genevisible; Q1PSW8; MM.
DR   GO; GO:0000932; C:P-body; IDA:UniProtKB.
DR   GO; GO:0035198; F:miRNA binding; IDA:UniProtKB.
DR   GO; GO:0030371; F:translation repressor activity; ISO:MGI.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:MGI.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0061158; P:3'-UTR-mediated mRNA destabilization; ISO:MGI.
DR   GO; GO:0071310; P:cellular response to organic substance; IDA:MGI.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0035278; P:miRNA mediated inhibition of translation; IMP:UniProtKB.
DR   GO; GO:0010586; P:miRNA metabolic process; IDA:UniProtKB.
DR   GO; GO:0017148; P:negative regulation of translation; ISO:MGI.
DR   GO; GO:0001843; P:neural tube closure; IMP:MGI.
DR   GO; GO:0021915; P:neural tube development; IDA:UniProtKB.
DR   GO; GO:2000637; P:positive regulation of gene silencing by miRNA; IDA:MGI.
DR   GO; GO:0010608; P:posttranscriptional regulation of gene expression; ISO:MGI.
DR   GO; GO:0035196; P:production of miRNAs involved in gene silencing by miRNA; ISS:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IBA:GO_Central.
DR   GO; GO:0060964; P:regulation of gene silencing by miRNA; IMP:UniProtKB.
DR   GO; GO:2000177; P:regulation of neural precursor cell proliferation; IMP:UniProtKB.
DR   GO; GO:0051246; P:regulation of protein metabolic process; IDA:MGI.
DR   GO; GO:0072089; P:stem cell proliferation; IMP:UniProtKB.
DR   Gene3D; 2.120.10.30; -; 2.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR011042; 6-blade_b-propeller_TolB-like.
DR   InterPro; IPR017868; Filamin/ABP280_repeat-like.
DR   InterPro; IPR001298; Filamin/ABP280_rpt.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR001258; NHL_repeat.
DR   InterPro; IPR013017; NHL_repeat_subgr.
DR   InterPro; IPR000315; Znf_B-box.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF00630; Filamin; 1.
DR   Pfam; PF01436; NHL; 6.
DR   Pfam; PF00643; zf-B_box; 1.
DR   SMART; SM00336; BBOX; 2.
DR   SMART; SM00557; IG_FLMN; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS50194; FILAMIN_REPEAT; 1.
DR   PROSITE; PS51125; NHL; 6.
DR   PROSITE; PS50119; ZF_BBOX; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Coiled coil; Cytoplasm; Developmental protein; Metal-binding;
KW   Reference proteome; Repeat; RNA-binding; RNA-mediated gene silencing;
KW   Transferase; Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q2Q1W2"
FT   CHAIN           2..855
FT                   /note="E3 ubiquitin-protein ligase TRIM71"
FT                   /id="PRO_0000279512"
FT   REPEAT          466..567
FT                   /note="Filamin"
FT   REPEAT          580..623
FT                   /note="NHL 1"
FT   REPEAT          627..670
FT                   /note="NHL 2"
FT   REPEAT          674..717
FT                   /note="NHL 3"
FT   REPEAT          721..764
FT                   /note="NHL 4"
FT   REPEAT          768..811
FT                   /note="NHL 5"
FT   REPEAT          815..855
FT                   /note="NHL 6"
FT   ZN_FING         12..94
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   ZN_FING         181..228
FT                   /note="B box-type 1; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   ZN_FING         260..301
FT                   /note="B box-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   COILED          314..352
FT                   /evidence="ECO:0000255"
FT   COILED          378..411
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        26..42
FT                   /note="Ser-rich"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q2Q1W2"
FT   MUTAGEN         12
FT                   /note="C->L: Abolishes E3 ubiquitin-protein ligase
FT                   activity; when associated with A-15."
FT                   /evidence="ECO:0000269|PubMed:19898466"
FT   MUTAGEN         15
FT                   /note="C->A: Abolishes E3 ubiquitin-protein ligase
FT                   activity; when associated with L-12."
FT                   /evidence="ECO:0000269|PubMed:19898466"
SQ   SEQUENCE   855 AA;  92054 MW;  151BA48E28C34904 CRC64;
     MASFPETDFQ ICLLCKEMCG SPAPLSSNSS ASSSSSQTST SSAGGGGPGA AARRLHVLPC
     LHAFCRPCLE AHRLPAPGGA GPAEALKLRC PVCDQKVVLA EAAGMDALPS SAFLLSNLLD
     AVVATAEEPP PKNGRAGGGP GGAGGHSNHR HHAHHPAQRA AAPAPQPPPG PAASPGSLLM
     RRPHGCSSCD EGNAASSRCL DCQEHLCDNC VRAHQRVRLT KDHYIERGPP GPAAASAAQQ
     LGLGPPFAGA PFSILSVFPE RLGFCQHHDD EVLHLYCDTC SVPICRECTL GRHGGHSFAY
     LQDALQDSRA LTIQLLADAQ QGRQALQLSI EQAQTVAEQV EMKAKVVQSE VKAVTARHKK
     ALEDRECELL WKVEKIRQVK AKSLFLQVEK LRQSLSKLES TISAVQQVLE EGRALDILLA
     RDRMLAQVQE LKTIRGLLQP QEDDRIMFTP PDQALYLALK SIGFVSSGAF APLTKATGDG
     IKRALQGKVA SFTVMGYDHD GEPRHSGGDL MSVVVLGPDG NLFGAEVSDQ QNGTYIVSYR
     PQLEGEHLVS VTLYNQHIEN SPFKVVVKSG RSYVGIGLPG LSFGSEGDGE GKLCRPWGVS
     VDKEGFIIVA DRSNNRIQVF KPCGSFHHKF GTLGSRPGQF DRPAGVACDA SRRIIVADKD
     NHRIQIFTFE GQFLLKFGEK GTKNGQFNYP WDVAVNSEGK ILVSDTRNHR IQLFGPDGVF
     LNKYGFEGSL WKHFDSPRGV AFNNEGHLVV TDFNNHRLLV IHPDCQSARF LGSEGSGNGQ
     FLRPQGVAVD QEGRIIVADS RNHRVQMFEA NGSFLCKFGA QGSGFGQMDR PSGIAVTPDG
     LIVVVDFGNN RILIF
//
